Beam Therapeutics (BEAM) Return on Sales by Net Profit

Graphic logo of Beam Therapeutics Corp (BEAM)

Beam Therapeutics Inc. (BEAM) focuses on the commercialization of precision base editing, raising capital through alliances with pharmaceutical behemoths. The net profit margin in the GURU.Markets chart data clearly illustrates efficiency, where the -73.00 level captures the latest values. The company mitigates risks by developing therapies for liver and blood pathologies, while its leadership in safe point genome editing and its patent portfolio provide a powerful defensive moat.

BEAM: Beam Tx Company Net Profitability 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company Beam Tx (BEAM)

- share price and expert price forecast:
- market capitalization details:
Analysis of all company metrics:Beam Therapeutics, BEAM
Flagship merchandise of Beam Therapeutics Corp

Investors are assessing the potential of Beam Therapeutics Inc. (BEAM) through the business's ability to convert revenue into net income, measured by the ratio of bottom-line earnings to total sales. Analyzing the sales margin trend reveals how colossal early-stage clinical trial expenses and gene-editing safety risks are suppressing current profitability, rendering the company's commercial break-even a distant hypothesis.

Who Beam Therapeutics Inc. competes with

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|SRPT: Return on Sales by Net Profit|Net Margin Twist Bioscience|TXG (10x Genomics) - Return on Sales by Net Profit|Intellia Therapeutics, Inc. (NTLA) - Net Sales Margin|Net Margin Stoke Therapeutics Inc|BLFS: Net Profit Rate|Return on Sales by Net Profit WVE (Wave Life Sciences Corp)|Company Sales Margin Maze Therapeutics Corp|Sionna Therapeutics Inc - Return on Sales by Net Profit|PRME (primemedicine.com) - Net Profit Margin|TSHA - Net Margin|QURE (uniQure) - Net Return on Sales|MeiraGTx Corp (MGTX) - Net Margin|Regenxbio - Net Profit Rate|Net Margin solidbio.com|Net Margin ocugen.com OCGN|Net Sales Margin PACB|Benitec - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX